Expanded Access of Axatilimab to Treat a Single Patient With Chronic Graft Versus Host Disease (GVHD)

NCT05544032 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Chronic Graft Vs. Host Disease

Interventions

DRUG: axatilimab

Sponsor

Incyte Corporation